Ivan D. Frantz III, MD
|Hospital Title||Medical Director, Neonatal and Perinatal Outreach|
|Academic Title||Clinical Professor of Pediatrics|
|Ivan D. Franz. III|
The major focus of my research has been on understanding aspects of neonatal pulmonary physiology in animal models and human infants and then using this knowledge to develop new approaches to treatment of neonatal lung disease. Specific examples include participation in early clinical trials of exogenous surfactant for treatment of respiratory distress syndrome, development of the technique of high frequency ventilation and understanding its physiologic implications, clinical trials of inhaled glucocorticoids for prevention of bronchopulmonary dysplasia, and participation in a trial of nasal intermittent positive pressure ventilation for preterm infants. Recently I have been involved in a wide range of clinical trials in preterm infants.
About Ivan D. Franz
My training in neonatology started at McGill with Mary Ellen Avery and in pulmonary physiology with Dr. Joseph Milic-Emili. I then moved to Harvard to continue working with Dr. Avery and Dr. Jere Mead at the Harvard School of Public Health. I spent several years as associate director of the Harvard Joint Program in Neonatology then moved to Tufts to direct the neonatology program there.
- Finer NN, Carlo W, Walsh MC, Rich W, Gantz M, Laptook AR, Yoder BA, Faix RG, Das A, Poole WK, Ambalavanan N, Schibler K, Donovan E, Newman N, Frantz ID, Sánchez PJ, Buchter S, Morris B, Laroia N, Poindexter BB, Cotton CM, Van Meurs KP, Sood B, Duara S, O’Shea TM, Bell EF, Bhandari V, Watterberg KL, Higgins RD, for the NICHD Neonatal Research Network. Early CPAP versus Surfactant in Very Preterm Infants: The SUPPORT Trial. N Engl J Med 2010. DOI: 10.1056/NEJMoa0911783
- Singh R, Visintainer P, Frantz III I, Shah B, Meyer K, Favila S, Thomas M, Kent D. Association of necrotizing enterocolitis with anemia and packed red blood cell transfusions in preterm infants. J Perinatology 2011; 31:176-182.
- Carlo WA; McDonald SA; Fanaroff AA; Vohr BR; Stoll BJ; Ehrenkranz RA; Andrews WW; Wallace D; Das A; Bell EF; Walsh MC; Laptook AR; Shankaran S; Poindexter BB; Hale EC; Newman NS; Davis AS; Schibler K; Kennedy KA; Sánchez PJ; Van Meurs KP; Goldberg RN; Watterberg KL; Faix RG; Frantz ID 3rd; Higgins RD; Association of antenatal corticosteroids with mortality and neurodevelopmental